Michielsen P P, Fierens H, Van Maercke Y M
Division of Gastroenterology, University Hospital of Antwerp, Edegem, Belgium.
Drug Saf. 1992 Jan-Feb;7(1):32-45. doi: 10.2165/00002018-199207010-00005.
A great variety of drugs is reported to induce gallbladder disease by various pathogenetic mechanisms. Early epidemiological studies indicated a doubled risk of gallbladder disease in women taking oral contraceptives. More recent studies, however, have failed to confirm those findings; these conflicting results might be explained by the different methods used to define gallbladder disease. It was shown that the lithogenic index of the bile is increased during intake of oral contraceptives. Estrogens cause hypersecretion of cholesterol in bile, due to increase in lipoprotein uptake by the hepatocyte. Progesterone inhibits acyl coenzyme A-cholesterol acyl transferase (ACAT) activity, causing delayed conversion of cholesterol to cholesterol esters. Of the lipid lowering drugs, only clofibrate has been shown to increase the risk for gallstone formation. The other fibric acid derivatives have similar properties, but clinical experience is not as extensive. They seem to be inhibitors of the ACAT enzyme system, thereby rendering bile more lithogenic. Conflicting epidemiological data exist regarding the induction of acute cholecystitis by thiazide diuretics. Ceftriaxone, a third-generation cephalosporin, is reported to induce biliary sludge in 25 to 45% of patients, an effect which is reversible after discontinuing the drug. The sludge is occasionally a clinical problem. It was clearly demonstrated that this sludge is caused by precipitation of the calcium salt of ceftriaxone excreted in the bile. Long term use of octreotide is complicated by gallstone formation in approximately 50% of patients after 1 year of therapy, due to gallbladder stasis. Hepatic artery infusion chemotherapy by implanted pump is shown to be associated with a very high risk of chemically induced cholecystitis. Prophylactic cholecystectomy at the time of pump implantation is therefore advocated. Some drugs, such as erythromcyin or ampicillin, are reported to cause hypersensitivity-induced cholecystitis. Furthermore, there are reports on the influence of cyclosporin, dapsone, anticoagulant treatment, and narcotic and anticholinergic medication in causing gallbladder disease.
据报道,各种各样的药物可通过多种致病机制诱发胆囊疾病。早期的流行病学研究表明,服用口服避孕药的女性患胆囊疾病的风险加倍。然而,最近的研究未能证实这些发现;这些相互矛盾的结果可能是由于用于定义胆囊疾病的方法不同所致。研究表明,口服避孕药期间胆汁的成石指数会升高。雌激素会导致胆汁中胆固醇分泌过多,这是由于肝细胞对脂蛋白的摄取增加所致。孕酮会抑制酰基辅酶A-胆固醇酰基转移酶(ACAT)的活性,导致胆固醇向胆固醇酯的转化延迟。在降脂药物中,只有氯贝丁酯被证明会增加胆结石形成的风险。其他纤维酸衍生物具有类似的性质,但临床经验并不那么广泛。它们似乎是ACAT酶系统的抑制剂,从而使胆汁更易形成结石。关于噻嗪类利尿剂诱发急性胆囊炎,存在相互矛盾的流行病学数据。据报道,第三代头孢菌素头孢曲松会使25%至45%的患者发生胆泥,停药后这种效应是可逆的。胆泥偶尔会成为临床问题。已明确证明,这种胆泥是由胆汁中排泄的头孢曲松钙盐沉淀引起的。长期使用奥曲肽会使约50%的患者在治疗1年后因胆囊淤滞而并发胆结石形成。通过植入泵进行肝动脉灌注化疗被证明与化学性胆囊炎的高风险相关。因此,提倡在植入泵时进行预防性胆囊切除术。据报道,一些药物,如红霉素或氨苄西林,会引起超敏反应性胆囊炎。此外,还有关于环孢素、氨苯砜、抗凝治疗以及麻醉和抗胆碱能药物对胆囊疾病影响的报道。